The eminent dry powder inhaler manufacturer in India

The contract research and manufacturing service industry in India is experiencing a robust growth owing to various factors like expertise manpower, technical asset, the growing number of contract research and manufacturing companies adhering to GMP compliance and most importantly the low cost manpower available in this country.

All these factors have enabled the Indian pharma manufacturer to make the Indian pharmaceutical industry to grow beyond 30 billion dollar industry and is expected to grow further, thus establishing Sava in India to be the most preferred universal outsourcing hub.

SAVA Global, the leading pharmaceutical manufacturing company in India constitutes deeply to providing comprehensive contract research and manufacturing services. This organization par excellence effectively delivers a diversified range of healthcare products as well as services across numerous geographies.

SAVA stands high in manufacturing, nasal spray and dry powder inhaler which added more to the company’s proud participation in CPHI. The manufacturing facility of nasal spray and dry powder inhaler of SAVA Global has won many accreditations owing to the specialty of the manufacturing unit thus proving SAVA Global to be the eminent dry powder inhaler manufacturer in India. These accreditations include:

• WHO-GMP
• SBP-Yemen
• Russia FDA
• PPB-Kenya 
• PMP-Malawi
• PIC/S -Ukraine
• PIC/S -Ukraine
• PAHO-USA
• NSD-Iran
• NDA -Uganda
• NAFDAC-Nigeria
• MOH-Kazakhstan
• MOH-Kazakhstan

The products manufactured by SAVA Global at this unit are: 

• Dry powder inhaler
• Nasal sprays
• Capsules
• Tablets
• Gels 
• Ointments

The specialty of the nasal spray and dry powder inhaler unit of SAVA Global: 

• Independent units for Nasal sprays, DPI and General Formulations
• Separate AHU for each unit
• Computerized HVAC
• Production areas made of sandwich panes and self-leveling PVC floorings
• Modern QA, QC, Microbiological and PD lab supported with high tech equipment 

SAVA produces wide range of dry powder for inhalers such as :

Salmetrol + Fluticasone Propionate Dry Powder for Inhalation

BUDESONIDE  + FORMOTEROL FUMARATE

BUDESONIDE

IPRATROPIUM BROMIDE

IPRATROPIUM BROMIDE + SALBUTAMOL SULPHATE

MOMETASONE FUROATE + FORMOTEROL FUMARATE

SALBUTAMOL SULPHATE + BECLOMETHASONE DIPROPIONATE

SALBUTAMOL SULPHATE

SALMETEROL + FLUTICASONE PROPIONATE

TIOTROPIUM BROMIDE + FORMETEROL FUMARATE DIHYDRATE

Dry powder inhaler frees one of poor inhalation techniques

Dry powder inhaler (DPI) is a modern device that is designed using the latest biotechnology so that it facilitates the delivery of medicines directly in the lungs to relieve one from various respiratory diseases like bronchitis, asthma, emphysema, and CODP. This latest treatment device is also used for the treatment of diabetes mellitus. 

DPI requires a procedure that gives the right measure dose of the medicine that has to be used for the patient. There are two ways of taking the medication, one way involves manual loading of the capsule and the other way involves a proprietary form from the inside of the inhaler.

The ideal way to use this is to out the inhaler mouthpiece in the mouth and then followed up by taking a deep inhalation holding the breath for 5 to 10 seconds. In this form of treatment there are a variety of devices available but the effect will be delivered from using the latest and the most approved devices for the same.

SAVA Global, a leading pharma manufacturer in India manufactures the most updated DPI. With its analytical development, formulation development and regulatory affairs along with proper strategy for logistics and distribution. SAVA ensures that it does provide the optimum healthcare service and products to its global customers.  

Among various dry powder inhaler manufacturers in India, SAVA is emerging as a strong player. The device that it manufactures facilitates proper air flow as it directly reaches the lungs. This makes it more effective and since SAVA Global uses the latest technology in manufacturing the same, the effect is more. No wonder DPI manufactured by it is the most recommended by medical practitioners all over the globe.

This top pharma company in India is self-possessed to meet global market volatility and competent enough for larger business profits in the forthcoming years not only in the DPI but also in providing other healthcare products and services.  

Sava Global excels in being the leading pharma company in India

Sava Global, esteemed in 2003 is one of the fastest developing pharmaceutical organizations from India. Its core aim is to provide consumer health care for the betterment of the society as a whole. It provides pharmaceutical drugs at wholesale rates and also excels in services like contract research & contract manufacturing thus enhancing global consumer care by making a constant effort to make it better and better.

In recent years, India has become the most preferred pharmaceutical hub owing to expertise knowledge and low cost labor available in this nation. SAVA Global with its state of the art facilities, unmatched quality control, progressive research expertise, highly qualified team of research and development scientists, has emerged as an outstanding outsourcing hub for contract research and contract manufacturing.

This pharma manufacturer in India has its units at two places in India, Surendranagar ( Gujarat) and Bangalore (Karnataka). These manufacturing facilities are specialized facilities owing to which they are highly accredited with WHO-GMP, Kenya PPB, Nigeria, Iran NSD, Russia FDA, ISO 22000:2005, ISO 9001:2000, NOP Organic, USDA, Halal and Koshar.

Sava with its top class infrastructure specializes in :

• Literature search & Primary Patent Evaluation
• Product  and Analytical Development Report
• Prototype Development of Dosage Form
• Scale-up & Process Optimization & Process Validation
• Technology Transfer
• Packaging Development
• Commercial custom manufacturing
• Dossier Documentation in CTD Format 

Sava’s global presence in more than 35 countries is marked with very good network of marketing and distribution. These include hiring skilled resources that are available in the domestic scenario; stimulating competition by developing alternate source of vendor and suppliers, reducing elongated lead times by increasing the total supply capacity, providing backup for the risk of port shutdowns, and finding solutions to resolve the hindrance of monitoring the quality of product.

Its wide spectrum of business in healthcare includes OTC, Biopharmaceutical in finished dosage form, phyto-medicines, API & intermediates have made it the leading Indian pharma company and also the wholesale pharmaceutical drug supplier from India.

Sava is well poised to meet sudden or emerging market volatility and garner larger  business profits in the coming years from its burgeoning exports to the target countries including Russia, Singapore, Kenya , Europe etc.

Indian pharmaceutical companies will experience a windfall due to falling Rupee & Obamacare

Contradictory to some industries the rupee depreciation is a much delight to the pharmaceutical industry In India. This is because the export oriented Indian pharmaceutical firms will get more rupees in return of every dollar that they earn.

However the Indian currency that has fallen 15% since May this year is expected to show losses as well as gain. The Indian pharma industry is moving towards Specialty generic drugs and this will lead to better price realization.

The president of United States Barack Obama’s healthcare plan known as Obamacare aims at making medical treatments affordable to every American. This puts the Indian pharma industry in a happy place as it sees a boost in its growth, especially for the Indian drug exporter.

This scope for growth also brings the demand for high quality due to the increasing number of  United States FDA audits although exports may be cheaper due to the decline of Indian rupee.

Every pharma manufacturing company in India including SAVA Global is well aware of this and is taking measures where there will be zero tolerance towards any such thing that is against the US FDA norms. Drug makers are trying hard to attain a balance between exposures and hedge by adopting as well as in the building calibrated approach. 

As per the current status, pharmaceutical drugs exporter in India exports to more than 220 countries in the world which includes Russia, Singapore, Kenya and Brazil. 

As per expert analysis generics will continue dominating the market while the patent protected products will have a share of 10% till 2015.

It is expected that that the Indian pharma industry as well as Indian pharma exporter will experience a profitable scenario in their growth in the coming years.

Sava is well poised to meet this market volatility and garner larger  business profits in the coming years from its burgeoning exports to the target countries including Russia, Singapore, Kenya , Europe etc.

SAVA Global- The strong pillar in the Indian pharmaceutical industry

SAVA Global is the top pharmaceutical company in India that is dedicated in making life better with its diversified top quality medicines and health care products for humans as well as animals. Being a key player in the Indian pharmaceutical industry, SAVA Global has pioneered  itself through its top quality products,  reliability, state of art technology, infrastructure backed with the vision of valuing life, making it beautiful and better.

India ranks third in the global pharmaceutical industry in terms of stands and volume, and ranks 14th in terms of value. SAVA Global plays a key player in the Indian pharma industry and provides various services, products, research and development as well as manufacturing services to clients with zero tolerance towards compromising on quality and quantity aspect. 

Its products include medicines and other health care products for human as well as animal health products. its health care products are formulated as per the latest research in the medical field and successful clinical trials.  These health care products are recommended by top medical specialist.

This Indian pharmacy company excels in being the top contract research and co-development company with the aid of its advanced research expertise and state of art infrastructure. Its services regarding executing formulation development projects are outstanding. Its core competencies include Literature Information & Primary Patent Evaluation, Prototype Development of Dosage Form, Packaging Development, Documentation in CTD Format, Product Development Report, Scale-up & Process Optimization & Process Validation and technology transfer.

Its contract manufacturing offers clients cost effective service with timely delivery of the same. Some of its unparalleled services with respect to quality and time management include optimization and process development, process scale up and validation, quality control and quality assurance, Preparation and international submission of Drug Master Files and Certificates of Suitability and bulk production. SAVA Global takes complete care of confidentiality in producing these services. 

This pharma company in India has also outshine in the field of research and development with eth view of manufacturing health care products and other related services. These are accomplished with the aid of latest research and excellent infrastructure facilities.

Its latest formulation development techniques backed with state of art infrastructure produces nasal spray, ointments, capsules, oral liquids, and tablets. 

Along with these its analytical development methods and strategies form a very crucial part of its R&D agenda and focuses on Method Validation - for Assay, Dissolution and Related Substances, Process Validation and Packing Validation, Dissolution Testing, Analytical Method Development for Assay, Dissolution and Related Substances, Stability Studies as per ICH Guidelines. 

This top pharmaceutical company in India has earned many accreditations that include WHO GMP, KENYA-PPB, PAHO-USA, ISO Certificate, NIGERIA-NAFDAC, IRAN-NSD, RUSSIA-FDA, and GMP certificate.